Patent · US Active

Vector comprising multiple homologous nucleotide sequences

US10072274B2 · kind B2 · utility

1Cited by
0References
3Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJan 5, 2017
Grant dateSep 11, 2018
Priority date
Expiry dateJan 5, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/22
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to vectors comprising two or more homologous nucleotide sequences and methods for generating them. The invention concerns substituting bases in the homologous nucleotide sequences with different bases that do not alter the encoded amino acid sequence. The invention allows for the reduction of intramolecular recombination between homologous nucleotide sequences, in particular in mammalian cells. The invention further relates to nucleotide sequences containing substituted bases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.